Understanding Ramifications & Control Strategy to Set Specifications for ADC Drug-Linker Impurities
- Detailing control strategies for controlling drug-linker impurities in ADCs, as outlined by the IQ Working Group
- Discussing phase-appropriate strategy for controlling ADC drug-linker impurities
- Understanding considerations for conjugatable versus non-conjugatable impurities